HealthDay News — No benefit of high-dose versus standard-dose rifampin is seen among adults with tuberculosis meningitis, according to a study published online Dec. 17 in the New England Journal of…
Category: 6. Health
-
The world risks forgetting one of humanity's greatest triumphs as polio nears global eradication – Medical Xpress
- The world risks forgetting one of humanity’s greatest triumphs as polio nears global eradication Medical Xpress
- The Conversation | Carl Kurlander | The world risks forgetting one of humanity’s greatest triumphs as polio nears global eradication
Continue Reading
-
Wearable AI device detects early signs of frailty in older adults
University of Arizona researchers in the Gutruf Lab have developed a comfortable, easy-to-use wearable device that incorporates artificial intelligence to detect subtle warning signs of frailty, signifying a leap forward in elderly…
Continue Reading
-
Menopause hormone therapy not linked to dementia risk in women
A major review of prior research has found no evidence that menopause hormone therapy either increases or decreases dementia risk in post-menopausal women, in a new study led by University College London (UCL) researchers.
The…
Continue Reading
-
THC products provide small improvements in pain but carry side effects
A new systematic evidence review finds that cannabis products that carry relatively high levels of the psychoactive compound tetrahydrocannabinol, commonly known as THC, may provide short-term improvements in pain and…
Continue Reading
-
Reframing the role of MCL1 in cancer signaling and metabolism
A study by the Mildred Scheel Early Career Center group led by Dr. Mohamed Elgendy at the TUD Faculty of Medicine provides fundamental insights into cancer biology. Published in the renowned journal Nature Communications, the study…
Continue Reading
-
New Drug Stalls Alzheimer’s Development in Breakthrough Trial : ScienceAlert
Growing evidence suggests that the key to treating Alzheimer’s is catching it in its earliest stages. Now scientists have developed a promising new drug that seems to be effective at stalling the disease before it really gets started.
The…
Continue Reading
-
A senescence-based therapeutic approach for temporal lobe epilepsy
Temporal lobe epilepsy, which results in recurring seizures and cognitive dysfunction, is associated with premature aging of brain cells. A new study from researchers at Georgetown University Medical Center found that this form of…
Continue Reading
-
Research highlights a potential therapeutic strategy for vascular dementia
A possible new treatment for impaired brain blood flow and related dementias is on the horizon. Research by scientists at the University of Vermont Robert Larner, M.D. College of Medicine provides novel insights into the mechanisms…
Continue Reading